Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 15/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4199851 | 1.00 | CYP19A1 (0.71) | CYP19A1CYP3A4LMNAMAPT | |
| SCHEMBL14027916 | 1.00 | CYP19A1 (0.71) | CYP19A1CYP3A4LMNAMAPT | |
| Acetone SCHEMBL9504391 | 0.96 | CYP19A1 (0.69) | CYP19A1CYP3A4LMNAMAPT | |
| SCHEMBL10882654 | 0.87 | CYP19A1 (0.70) | CYP19A1CYP3A4LMNAMAPT | |
| SCHEMBL11365883 | 0.87 | CYP19A1 (0.54) | CYP19A1CYP3A4LMNAMAPT | |
| SCHEMBL10895875 | 0.86 | CYP19A1 (0.69) | CYP19A1CYP3A4LMNAMAPT | |
| SCHEMBL9015138 | 0.86 | CYP19A1 (0.69) | CYP19A1CYP3A4LMNAMAPT | |
| SCHEMBL29904015 | 0.85 | CYP19A1 (0.71) | CYP19A1CYP3A4LMNAMAPT | |
| SCHEMBL24101855 | 0.85 | CYP19A1 (0.69) | CYP19A1CYP3A4LMNAMAPT | |
| SCHEMBL14046282 | 0.84 | CYP19A1 (0.76) | CYP19A1CYP3A4LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2024383-A2 | CRYSTALLINE FORMS OF 11 BETA-(4-ACETYLPHENYL)-20,20,21,21,21-PENTAFLUOR-17ALPHA- HYDROXY-19-NOR-17 -PREGNA-4,9-DIEN-3-ONE | Bayer Schering Pharma Aktiengesellschaft (DE) | 2009-02-18 | — | — | EP | claimed |
| WO-2007140917-A2 | CRYSTALLINE FORMS OF 11 ß-(4-ACETYLPHENYL)-20,20,21,21,21-PENTAFLUOR-17- HYDROXY-19-NOR-17α-PREGNA-4,9-DIEN-3-ONE | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-12-13 | — | — | WO | claimed |
| EP-2024383-A2 | CRYSTALLINE FORMS OF 11 BETA-(4-ACETYLPHENYL)-20,20,21,21,21-PENTAFLUOR-17ALPHA- HYDROXY-19-NOR-17 -PREGNA-4,9-DIEN-3-ONE | Bayer Schering Pharma Aktiengesellschaft (DE) | 2009-02-18 | — | — | EP | disclosed |
| WO-2007140917-A2 | CRYSTALLINE FORMS OF 11 ß-(4-ACETYLPHENYL)-20,20,21,21,21-PENTAFLUOR-17- HYDROXY-19-NOR-17α-PREGNA-4,9-DIEN-3-ONE | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-12-13 | — | — | WO | disclosed |